The largest database of trusted experimental protocols

Fitc conjugated anti mouse cd8a

Manufactured by BD
Sourced in Australia

The FITC-conjugated anti-mouse CD8a is a laboratory reagent used for the detection and quantification of CD8a-positive cells in mouse samples. It is a monoclonal antibody conjugated with the fluorescent dye FITC (Fluorescein Isothiocyanate) that specifically binds to the CD8a surface marker on cells.

Automatically generated - may contain errors

6 protocols using fitc conjugated anti mouse cd8a

1

Flow Cytometry Analysis of RT-specific CD8+ T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
All of the procedures were performed as previously described in109 (link). Briefly, splenocytes of RT-immunized or vector-immunized mice were stimulated with RT-derived peptides RT202–210 wt, RT202–210 dr, RT207–215 wt, RT207–215 dr, RT205–220 wt, and RT205–220 dr (Table 2) and stained for viability with the Fixable Viability Stain 660 (FSV660; BD Horizon #564405). Thereafter, cell surface staining was performed with a mixture of antibodies including FITC-conjugated anti-mouse CD8a (BD Pharmingen #553031), APC-H7-conjugated anti-mouse CD4 (BD Pharmingen #560181), and PerCP-conjugated anti-mouse CD3 (BD Pharmingen #553067). The cells were then fixed, permeabilized, washed, and stained with PE-Cy7-conjugated anti-mouse IFN-γ antibodies (BD Pharmingen #557649). Stained samples were analysed on a FACSVerse cytometer (BD Biosciences, USA). Data were exported as FCS3.0 files with the use of FACSuite software and read using BioConductor’s127 (link) package flowCore128 (link) in the R software package. Final normalization of the data was performed with the flowStats package129 (link) and the data were gated. First, a general lymphocyte area was defined and viable cells were identified by the lack of FSV660 staining. From the viable population, single cells were defined by the expression of surface markers and IFN-γ production.
+ Open protocol
+ Expand
2

Quantifying HPV16 E7-specific CD8+ T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Groups of C57BL/6 mice (5 per group) were challenged with TC-1 tumor cells and treated with bortezomib and/or SAHA as described above. To detect HPV16 E7-specific CD8+ T cells in peripheral blood, peripheral blood mononuclear cells (PBMCs) were harvested from the tail vein one week after the last treatment. The cells were stained with FITC-conjugated anti-mouse CD8a (BD Pharmingen, San Diego, CA, USA) and PE-conjugated HPV16 E7 aa49-57 peptide loaded H-2Db tetramer and acquired with FACSCalibur.
To detect HPV16 E7-specific CD8+ T cells in the tumor, single cell suspensions were stimulated with HPV16 E7 aa49-57 peptide (1 μg/ml) in the presence of GolgiPlug (BD Pharmingen, San Diego, CA, USA) overnight at 37°C. The cells were then stained with PE-conjugated anti-mouse CD8a. After permeabilization and fixation, the cells were stained with FITC-conjugated anti-mouse IFN-γ followed by flow cytometry analysis. The data were analyzed with FlowJo or CellQuest Pro software.
+ Open protocol
+ Expand
3

Multiparametric Flow Cytometry Analysis of Lymphocyte Subsets

Check if the same lab product or an alternative is used in the 5 most similar protocols
Lymphocyte subpopulations among splenocytes were analyzed with a flow cytometer (Beckman Coulter, Inc.) following standard surface staining procedures using the appropriately diluted antibodies as follows: PE-conjugated anti-mouse CD4 (1:100, cat. no. 553730, BD Biosciences), FITC-conjugated anti-mouse CD8a (1:100, cat. no. 553031, BD Biosciences), PE/Cy7-conjugated anti-mouse CD25 (1:100, cat. no. 60-0251, Tonbo Biosciences) and isotype control antibodies (1:100, cat. no. 553989, cat. no. 553929, BD Biosciences; cat. no. 60-430, cat. no. 35-4714, Tonbo Biosciences) (the cells were incubated with the antibodies at 4°C for 30 min). For the confirmation of FoxP3-expressing Tregs and interferon (IFN)-γ-expressing CD8+ T cells, standard surface staining procedures were combined with an intracellular staining method using FITC-conjugated anti-mouse FoxP3 (1:100, cat. no. 35-5773, Tonbo Biosciences) and PE/Cy7-conjugated anti-mouse IFN-γ (1:100, cat. no. 561040, BD Biosciences) antibodies, respectively. For the intracellular FoxP3 and IFN-γ titration, the cells were pre-incubated with Protein Transport Inhibitor containing Monensin (BD Biosciences) at 37°C for 6 h prior to harvesting the cells. Quantification was performed by FACS analysis using a Beckman Coulter FC500 (Beckman Coulter, Inc.).
+ Open protocol
+ Expand
4

Tumor Immune Cell Profiling by Flow Cytometry

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tumor-infiltrating and splenic lymphocytes were analyzed by flow cytometry. In brief, tumor and spleen tissues were harvested and digested with collagenase A and hyaluronidase at 37 °C for 40 min. After lysis of the red blood cells (RBCs), the dissociated cells were dispersed with 1 mL of HBSS. For intracellular cytokine staining, the cells from the tumor and spleen tissue were permeabilized with 0.1% triton X-100 for 15 min. The density of total cells was 5×106/mL. The tumor infiltrating immune cells were stained with the following fluorescence-labeled antibodies: FITC-conjugated anti-mouse CD8a, FITC-conjugated anti-mouse CD4, PE-conjugated anti-mouse Foxp3, FITC-conjugated anti-mouse CD11b, and PE-conjugated anti-mouse Gr-1 (BD, New South Wales, Australia). Flow cytometry was performed in quintuplicate for each group. Analysis was performed on a FACSCalibur flow cytometer and analyzed using Cell Quest software (BD Biosciences, San Jose, CA).
+ Open protocol
+ Expand
5

Quantifying HPV16 E7-specific CD8+ T cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Groups of C57BL/6 mice (5 mice/group) were challenged with TC-1 tumor cells and treated with 3-BrPA as described above. To detect HPV16 E7-specific CD8+ T cells in the spleen, splenocytes were harvested from the spleen one week after the last treatment. The cells were stained with FITC-conjugated anti-mouse CD8a (BD Pharmingen, San Diego, CA) and PE-conjugated HPV16 E7 aa49–57 peptide loaded H-2Db tetramer and acquired with FACSCalibur. To detect HPV16 E7-specific CD8+ T cells in the tumor, single cell suspensions were stimulated with HPV16 E7 aa49–57 peptide (1 μg/mL) in the presence of GolgiPlug (BD Pharmingen, San Diego, CA) overnight at 37 °C. The cells were then stained with PE-conjugated antimouse CD8a. After permeabilization and fixation, the cells were stained with FITC-conjugated anti-mouse IFN-γ followed by flow cytometry analysis.
+ Open protocol
+ Expand
6

Tumor and Spleen Immune Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tumor-infiltrating and splenocyte immune lymphocytes were analyzed by flow cytometry. In brief, tumor and spleen tissues were harvested and digested with collagenase A and hyaluronidase at 37°C for 40 min. After lysis of the red blood cells (RBCs), the dissociated cells were dispersed with 1 mL of PBS. For intracellular cytokine staining, the cells from the tumor and spleen tissue were penetrated with 0.1% triton-100 for 15 min. The immune lymphocytes (5×106/mL) were stained with the following fluorescein-conjugated antibodies: FITC-conjugated anti-mouse CD8a, FITC-conjugated anti-mouse CD4, PE-conjugated anti-mouse FOXP3, FITC-conjugated anti-mouse CD11b, and PE-conjugated anti-mouse Gr-1 (BD, New South Wales, Australia). Flow cytometry was performed in quintuplicate for each group. Analysis was performed on a FACSCalibur flow cytometer and analyzed using Cell Quest software (BD Biosciences, San Jose, CA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!